Skip to main content

Coronary Artery Disease

Machine learning analysis of integrated ABP and PPG signals towards early detection of coronary artery disease


Every year, Coronary Artery Disease (CAD) claims lives of over a million people. CAD occurs when the coronary arteries, responsible for supplying oxygenated blood to the heart, get occluded due to plaque deposits on their inner walls. The most critical fact about this disease is that it develops gradually over the years and by the time symptomatic changes such as angina or shortness of breath appear, the disease has already become severe. The overall aim of the proposed work is to detect CAD efficiently in its early stage while utilizing (radial) arterial blood pressure (ABP) along with photoplethysmogram (PPG) signals so that necessary clinical measures may be taken timely.

To achieve this objective, firstly, ABP and PPG data of 73 CAD and 64 non-CAD (not suffering from any cardiac condition) subjects have been collected from MIMIC-II waveform database with matched subset. Secondly, the collected data is pre-processed using band pass filters having bandwidths of 2.5 to 16 Hz and 1.5 to 16 Hz for ABP and PPG respectively. Thirdly, nineteen features have been extracted from each of the two signals; some of the key features include mean of pulse duration, mean of rising slope and ratio of low frequency to high frequency. Finally, extensive analysis on CAD and non-CAD classification is carried out on the basis of extracted features while employing state-of-the-art classifiers such as support vector machines (SVM), K-nearest neighbors (KNN) and neural networks(NN).

The numerical experiments have led to the interpretation that neural network outperforms other classifiers, claiming an accuracy of about 90%. Moreover, accuracy of the proposed approach is found to be better than the state-of-the-art works reported in literature where one of or combinations of cardiovascular signals, namely, electrocardiogram (ECG), phonocardiogram (PCG) and photoplethysmogram (PPG) have been utilized for the CAD detection.

The global mortality rate due to cardiovascular diseases (CVDs) cause a major concern, approximately 17.9 million deaths in 2019 is being attributed to CVDs. Coronary artery disease is one of the major CVDs; in this pathological condition, the coronary arteries, responsible for supplying oxygenated blood to the heart, get occluded due to plaque deposits on their inner walls. This may further lead to symptoms such as chest pain, shortness of breath, heart attack in the advanced stage of disease development.

The risk factors include high blood pressure, high cholesterols, diabetes, smoking, obesity and a family history of heart disease. Treatment options for the said condition range from lifestyle changes, medication to surgery. It may be noted that once the disease has become severe, it requires clinical intervention, else, it may prove to be fatal. While coronary catheterization is a gold standard for diagnosing CAD, it is an invasive and expensive procedure conducted by skilled cardiologists.

A comparison can demonstrate the effectiveness of our proposed method over other techniques used. Firstly, validation using external datasets from different institutions or equipment was not conducted. Secondly, the proposed method could not be compared with previous methods within the same analytical environment. Additionally, in this study we have extracted the features manually further the use of deep neural networks for classification on CAD can be implemented.

For future work, enhancements can focus on improving the generalization of the dataset and incorporating deep learning methodologies. Additionally, a more comprehensive analysis of other potential features could be explored to further refine the model’s performance.

Coronary heart disease, atherosclerosis, cardiovascular disease, heart attack, myocardial infarction, angina, ischemia, plaque buildup, cholesterol, hypertension, blood pressure, arterial blockage, heart failure, risk factors, prevention, lifestyle changes, heart health, cardiology, medical treatment, diagnosis

#HeartDisease, #CardiovascularHealth, #HeartAttack, #Atherosclerosis, #Hypertension, #Cholesterol, #BloodPressure, #HeartHealth, #Cardiology, #Prevention, #HealthyLifestyle, #Angina, #Ischemia, #PlaqueBuildup, #MedicalTreatment, #Diagnosis, #RiskFactors, #HeartFailure, #ArterialBlockage


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...